Psoralen [EPC]

Psoralen [EPC] was reported 127 times

Drugs of the Psoralen [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 EPIGLOTTITIS HAEMOPHILUS 1 0.2500
1 CONJUNCTIVAL PRIMARY ACQUIRED MELANOSIS 1 0.1250
2 INFUSION SITE EXFOLIATION 1 0.0192
3 VOGT-KOYANAGI-HARADA DISEASE 4 0.0182
4 ABDOMINAL WALL OEDEMA 1 0.0159
5 CUTANEOUS T-CELL LYMPHOMA RECURRENT 1 0.0159
6 RETINOPATHY HAEMORRHAGIC 1 0.0152
7 CORNEAL ABSCESS 1 0.0093
8 MUCOCUTANEOUS ULCERATION 2 0.0088
9 SUBCORNEAL PUSTULAR DERMATOSIS 1 0.0081
10 RASH PAPULOSQUAMOUS 1 0.0066
11 NIPPLE DISORDER 4 0.0064
12 OESOPHAGEAL DILATION PROCEDURE 1 0.0060
13 ANAEMIA OF CHRONIC DISEASE 5 0.0055
14 ADULTERATED PRODUCT 1 0.0050
15 ORAL DYSAESTHESIA 1 0.0049
16 DISSEMINATED CYTOMEGALOVIRAL INFECTION 1 0.0046
17 CONGENITAL PULMONARY VALVE ATRESIA 1 0.0045
18 GRIP STRENGTH 1 0.0044
19 GRAFT VERSUS HOST DISEASE IN LIVER 3 0.0042
20 LATEX ALLERGY 1 0.0041
21 PARAPSORIASIS 1 0.0037
22 SUDDEN VISUAL LOSS 1 0.0036
23 LYMPHOMATOID PAPULOSIS 1 0.0034
24 ACANTHOSIS 1 0.0030
25 OESOPHAGEAL MOTILITY DISORDER 1 0.0028
26 CHOROIDITIS 1 0.0027
27 COAGULATION TEST ABNORMAL 2 0.0026
28 MYCOSIS FUNGOIDES 2 0.0024
29 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 5 0.0023
30 CHRONIC CUTANEOUS LUPUS ERYTHEMATOSUS 1 0.0022
31 PNEUMONIA HAEMOPHILUS 1 0.0021
32 FLAT AFFECT 4 0.0017
33 LEIOMYOMA 1 0.0014
34 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 1 0.0014
35 GRAFT VERSUS HOST DISEASE IN SKIN 3 0.0014
36 BLISTER RUPTURE 1 0.0013
37 SYSTEMIC LUPUS ERYTHEMATOSUS RASH 1 0.0013
38 SPUTUM CULTURE POSITIVE 1 0.0012
39 SEROUS RETINAL DETACHMENT 1 0.0012
40 SKIN HYPOPIGMENTATION 2 0.0011
41 MACULOPATHY 4 0.0011
42 ANOGENITAL WARTS 1 0.0011
43 CHRONIC GRAFT VERSUS HOST DISEASE 4 0.0011
44 CERUMEN IMPACTION 1 0.0011
45 COLOUR BLINDNESS 1 0.0011
46 MICROANGIOPATHY 1 0.0011
47 DELAYED RECOVERY FROM ANAESTHESIA 1 0.0011
48 LYMPHOCYTIC INFILTRATION 1 0.0010
49 BUTTERFLY RASH 1 0.0010
50 RETINAL TOXICITY 1 0.0010
51 TRAUMATIC HAEMATOMA 1 0.0009
52 OCULAR TOXICITY 1 0.0009
53 DYSFUNCTIONAL UTERINE BLEEDING 1 0.0008
54 CUTANEOUS T-CELL LYMPHOMA 1 0.0008
55 LUPUS VULGARIS 1 0.0008
56 RETINAL DEGENERATION 1 0.0008
57 SKIN DISCOMFORT 2 0.0007
58 CULTURE URINE POSITIVE 1 0.0007
59 PORPHYRIA ACUTE 1 0.0007
60 ADENOVIRUS INFECTION 2 0.0007
61 EXCESSIVE EYE BLINKING 1 0.0007
62 SQUAMOUS CELL CARCINOMA OF SKIN 4 0.0007
63 GENITAL HERPES 1 0.0007
64 GASTROSTOMY 1 0.0006
65 PAPILLOMA VIRAL INFECTION 1 0.0006
66 SKIN WOUND 1 0.0006
67 PUSTULAR PSORIASIS 2 0.0006
68 ACUTE SINUSITIS 1 0.0006
69 RETINITIS 1 0.0006
70 FAILURE TO THRIVE 3 0.0006
71 X-RAY ABNORMAL 1 0.0006
72 SOFT TISSUE INFECTION 1 0.0005
73 METAMORPHOPSIA 1 0.0005
74 IRON DEFICIENCY ANAEMIA 5 0.0005
75 LUPUS NEPHRITIS 1 0.0005
76 OCCULT BLOOD POSITIVE 1 0.0005
77 DEEP VEIN THROMBOSIS POSTOPERATIVE 1 0.0005
78 DERMATITIS PSORIASIFORM 1 0.0005
79 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1 0.0005
80 SPINA BIFIDA 1 0.0005
81 VASCULAR OCCLUSION 1 0.0005
82 GASTRIC BYPASS 1 0.0005
83 VASCULAR DEVICE INFECTION 2 0.0004
84 DISLOCATION OF VERTEBRA 1 0.0004
85 VITILIGO 1 0.0004
86 ESCHERICHIA BACTERAEMIA 1 0.0004
87 CONTRAST MEDIA REACTION 1 0.0004
88 PUSTULE 1 0.0004
89 BLOOD IMMUNOGLOBULIN E INCREASED 1 0.0004
90 GLOMERULONEPHRITIS 1 0.0004
91 NEUTROPHIL COUNT INCREASED 4 0.0004
92 ANGIONEUROTIC OEDEMA 1 0.0004
93 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0004
94 DRUG TOLERANCE DECREASED 1 0.0004
95 FIBULA FRACTURE 1 0.0003
96 TALIPES 1 0.0003
97 BASAL CELL CARCINOMA 5 0.0003
98 SWOLLEN JOINT COUNT INCREASED 1 0.0003
99 HAEMOGLOBIN ABNORMAL 2 0.0003
100 SKIN EROSION 1 0.0003
101 PORTAL VEIN THROMBOSIS 1 0.0003
102 FACET JOINT SYNDROME 1 0.0003
103 FOLLICULITIS 3 0.0003
104 BONE EROSION 1 0.0003
105 PARADOXICAL DRUG REACTION 1 0.0003
106 MUSCLE HAEMORRHAGE 1 0.0002
107 PERIPHERAL VENOUS DISEASE 1 0.0002
108 GENERALISED OEDEMA 3 0.0002
109 EOSINOPHIL COUNT INCREASED 2 0.0002
110 CYTOMEGALOVIRUS INFECTION REACTIVATION 1 0.0002
111 RHINITIS ALLERGIC 1 0.0002
112 RHEUMATIC FEVER 1 0.0002
113 JOINT RANGE OF MOTION DECREASED 3 0.0002
114 IRON DEFICIENCY 1 0.0002
115 LEUKOCYTOSIS 4 0.0002
116 FEELING OF DESPAIR 1 0.0002
117 SQUAMOUS CELL CARCINOMA 2 0.0002
118 ABORTION INDUCED 2 0.0002
119 FAECAL INCONTINENCE 1 0.0002
120 RASH VESICULAR 1 0.0002
121 LIVER INJURY 5 0.0002
122 HYPERVOLAEMIA 1 0.0002
123 DERMATITIS EXFOLIATIVE 1 0.0002
124 DRUG TOLERANCE 1 0.0002
125 DYSLIPIDAEMIA 1 0.0002
126 TRISMUS 1 0.0002
127 SKIN CANCER 4 0.0002
128 HYDROCEPHALUS 1 0.0002
129 SKIN LESION 5 0.0002
130 HYPERKERATOSIS 1 0.0002
131 WOUND 5 0.0002
132 RHEUMATOID FACTOR POSITIVE 1 0.0002
133 SOCIAL AVOIDANT BEHAVIOUR 1 0.0002
134 METABOLIC DISORDER 1 0.0002
135 PRODUCT LABEL CONFUSION 1 0.0002
136 PLATELET COUNT ABNORMAL 1 0.0002
137 C-REACTIVE PROTEIN ABNORMAL 1 0.0002
138 PROCTALGIA 1 0.0002
139 BREAST CANCER STAGE III 1 0.0002
140 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1 0.0002
141 WALKING AID USER 1 0.0002
142 PRODUCT FORMULATION ISSUE 1 0.0002
143 TERMINAL STATE 1 0.0001
144 DUODENAL ULCER 1 0.0001
145 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1 0.0001
146 GRAFT VERSUS HOST DISEASE 1 0.0001
147 VISUAL FIELD DEFECT 1 0.0001
148 RASH PUSTULAR 1 0.0001
149 URINARY INCONTINENCE 4 0.0001
150 DUODENAL ULCER PERFORATION 1 0.0001
151 PEMPHIGOID 1 0.0001
152 AORTIC ANEURYSM 1 0.0001
153 HIP ARTHROPLASTY 2 0.0001
154 MATERNAL DRUGS AFFECTING FOETUS 1 0.0001
155 MULTIPLE ALLERGIES 1 0.0001
156 DYSPHAGIA 12 0.0001
157 FURUNCLE 1 0.0001
158 OBESITY 2 0.0001
159 OSTEONECROSIS 4 0.0001
160 MUSCLE INJURY 1 0.0001
161 PERICARDITIS 2 0.0001
162 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 2 0.0001
163 PSEUDOMONAS INFECTION 1 0.0001
164 GASTRIC DISORDER 4 0.0001
165 GRIP STRENGTH DECREASED 1 0.0001
166 SYNOVITIS 2 0.0001
167 LUPUS-LIKE SYNDROME 1 0.0001
168 LIP DRY 1 0.0001
169 EXOSTOSIS 1 0.0001
170 APPENDICITIS 1 0.0001
171 PULMONARY FIBROSIS 2 0.0001
172 PANCREATIC CARCINOMA 3 0.0001
173 HYPERCHOLESTEROLAEMIA 1 0.0001
174 AUTOIMMUNE DISORDER 1 0.0001
175 LIGAMENT SPRAIN 1 0.0001
176 CARDIAC FAILURE 8 0.0001
177 HELICOBACTER INFECTION 1 0.0001
178 JOINT DISLOCATION 1 0.0001
179 DRUG INTOLERANCE 9 0.0001
180 LIVER FUNCTION TEST INCREASED 2 0.0001
181 WOUND INFECTION 1 0.0001
182 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1 0.0001
183 FOOT DEFORMITY 1 0.0001
184 SKIN INFECTION 1 0.0001
185 IMPAIRED DRIVING ABILITY 1 0.0001
186 SCAB 1 0.0001
187 MUSCLE TWITCHING 2 0.0001
188 SEXUAL DYSFUNCTION 1 0.0001
189 SYSTEMIC LUPUS ERYTHEMATOSUS 3 0.0001
190 BACTERAEMIA 1 0.0001
191 MACULAR DEGENERATION 1 0.0001
192 BURSITIS 1 0.0001
193 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
194 HYPERCALCAEMIA 1 0.0001
195 APPLICATION SITE IRRITATION 1 0.0001
196 PEMPHIGUS 1 0.0001
197 SECRETION DISCHARGE 1 0.0001
198 DERMATITIS ALLERGIC 1 0.0001
199 HAEMATEMESIS 2 0.0001
200 SKIN ULCER 2 0.0001
201 INJECTION SITE INDURATION 1 0.0001
202 HAND DEFORMITY 1 0.0001
203 JOINT STIFFNESS 2 0.0001
204 DEPRESSED MOOD 4 0.0001
205 FEBRILE NEUTROPENIA 5 0.0001
206 MALIGNANT MELANOMA 1 0.0001
207 DRUG TOXICITY 1 0.0001
208 IMPAIRED GASTRIC EMPTYING 1 0.0001
209 HAEMOPTYSIS 2 0.0001
210 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
211 RED BLOOD CELL COUNT DECREASED 2 0.0001
212 RENAL INJURY 2 0.0001
213 CATARACT 4 0.0001
214 COLON CANCER 1 0.0001
215 OSTEOPENIA 1 0.0001
216 ILL-DEFINED DISORDER 4 0.0001
217 DISCOMFORT 4 0.0001
218 DEVICE RELATED INFECTION 1 0.0001
219 PULMONARY EMBOLISM 6 0.0001
220 SCIATICA 1 0.0001
221 ABSCESS 1 0.0001
222 IMPAIRED HEALING 2 0.0001
223 PHOTOSENSITIVITY REACTION 1 0.0001
224 DRUG LEVEL INCREASED 1 0.0001
225 CYTOMEGALOVIRUS INFECTION 1 0.0001
226 CANDIDA INFECTION 1 0.0001
227 HAEMATURIA 2 0.0001
228 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
229 HEAD DISCOMFORT 1 0.0001
230 MOBILITY DECREASED 4 0.0001
231 OEDEMA 3 0.0001
232 CONJUNCTIVITIS 1 0.0001
233 BLISTER 3 0.0001
234 HEPATIC CIRRHOSIS 1 0.0001
235 PHOTOPHOBIA 1 0.0001
236 BLOOD SODIUM DECREASED 1 0.0001
237 BLOOD URINE PRESENT 1 0.0001
238 PROTEINURIA 1 0.0001
239 SLEEP APNOEA SYNDROME 1 0.0001
240 LOWER LIMB FRACTURE 1 0.0001
241 HERNIA 1 0.0001
242 EAR PAIN 1 0.0001
243 HAEMORRHOIDS 1 0.0001
244 BLOOD PRESSURE ABNORMAL 1 0.0001
245 PREGNANCY 1 0.0000
246 TASTE DISORDER 1 0.0000
247 INJECTION SITE WARMTH 1 0.0000
248 KNEE ARTHROPLASTY 1 0.0000
249 MOUTH ULCERATION 1 0.0000
250 IRRITABLE BOWEL SYNDROME 1 0.0000
251 RECTAL HAEMORRHAGE 2 0.0000
252 TRANSAMINASES INCREASED 1 0.0000
253 GLOSSODYNIA 1 0.0000
254 HEART RATE IRREGULAR 1 0.0000
255 PERICARDIAL EFFUSION 1 0.0000
256 BLOOD CHOLESTEROL INCREASED 2 0.0000
257 NEUROPATHY PERIPHERAL 4 0.0000
258 RASH ERYTHEMATOUS 2 0.0000
259 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
260 FIBROMYALGIA 1 0.0000
261 CEREBRAL INFARCTION 1 0.0000
262 DYSPEPSIA 4 0.0000
263 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
264 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
265 HYPOPHAGIA 1 0.0000
266 ERECTILE DYSFUNCTION 1 0.0000
267 ABDOMINAL DISTENSION 4 0.0000
268 APPLICATION SITE ERYTHEMA 1 0.0000
269 DERMATITIS ATOPIC 2 0.0000
270 PANCREATITIS 2 0.0000
271 DRUG INTERACTION 6 0.0000
272 EAR INFECTION 1 0.0000
273 PAIN OF SKIN 1 0.0000
274 FREQUENT BOWEL MOVEMENTS 1 0.0000
275 BLOOD BILIRUBIN INCREASED 1 0.0000
276 THROAT TIGHTNESS 1 0.0000
277 LIMB INJURY 1 0.0000
278 PNEUMONITIS 1 0.0000
279 OFF LABEL USE 32 0.0000
280 RESPIRATORY DISTRESS 1 0.0000
281 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
282 LABORATORY TEST ABNORMAL 1 0.0000
283 WHEEZING 2 0.0000
284 GASTROINTESTINAL DISORDER 3 0.0000
285 RESPIRATORY DISORDER 1 0.0000
286 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
287 CONSTIPATION 7 0.0000
288 NIGHT SWEATS 1 0.0000
289 PSORIASIS 4 0.0000
290 ABDOMINAL PAIN 7 0.0000
291 VIRAL INFECTION 1 0.0000
292 FUNGAL INFECTION 1 0.0000
293 ABDOMINAL DISCOMFORT 5 0.0000
294 VOMITING 14 0.0000
295 TYPE 2 DIABETES MELLITUS 1 0.0000
296 DRUG EXPOSURE DURING PREGNANCY 1 0.0000
297 DELIRIUM 1 0.0000
298 LYMPHADENOPATHY 1 0.0000
299 C-REACTIVE PROTEIN INCREASED 1 0.0000
300 WEIGHT INCREASED 6 0.0000
301 CONDITION AGGRAVATED 8 0.0000
302 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
303 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
304 DRY MOUTH 2 0.0000
305 PSORIATIC ARTHROPATHY 1 0.0000
306 OSTEOPOROSIS 1 0.0000
307 VISUAL IMPAIRMENT 3 0.0000
308 TREATMENT FAILURE 2 0.0000
309 ROAD TRAFFIC ACCIDENT 1 0.0000
310 SKIN EXFOLIATION 2 0.0000
311 OSTEOARTHRITIS 1 0.0000
312 PRURITUS 9 0.0000
313 LIVER DISORDER 1 0.0000
314 COLITIS ULCERATIVE 1 0.0000
315 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
316 THERAPY NON-RESPONDER 1 0.0000
317 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
318 SKIN DISCOLOURATION 1 0.0000
319 RENAL DISORDER 1 0.0000
320 SWELLING 2 0.0000
321 CONTUSION 2 0.0000
322 LUNG DISORDER 1 0.0000
323 HYPOAESTHESIA 3 0.0000
324 DRY EYE 1 0.0000
325 LEUKOPENIA 1 0.0000
326 CELLULITIS 1 0.0000
327 INFLAMMATION 1 0.0000
328 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
329 MUSCULOSKELETAL PAIN 1 0.0000
330 BRADYCARDIA 1 0.0000
331 RASH PRURITIC 1 0.0000
332 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
333 ARTHROPATHY 1 0.0000
334 PANCYTOPENIA 1 0.0000
335 THROMBOCYTOPENIA 2 0.0000
336 RHEUMATOID ARTHRITIS 2 0.0000
337 PRODUCT SUBSTITUTION ISSUE 1 0.0000
338 NASAL CONGESTION 1 0.0000
339 JOINT SWELLING 2 0.0000
340 THERAPEUTIC RESPONSE DECREASED 1 0.0000
341 STOMATITIS 1 0.0000
342 OEDEMA PERIPHERAL 2 0.0000
343 MUSCLE SPASMS 3 0.0000
344 FEELING HOT 1 0.0000
345 HYPERSENSITIVITY 3 0.0000
346 PRODUCT USE IN UNAPPROVED INDICATION 4 0.0000
347 GAIT DISTURBANCE 3 0.0000
348 RHINORRHOEA 1 0.0000
349 AMNESIA 1 0.0000
350 PRODUCT DOSE OMISSION 1 0.0000
351 BLOOD CREATININE INCREASED 1 0.0000
352 INFUSION RELATED REACTION 1 0.0000
353 DEHYDRATION 2 0.0000
354 HYPOTENSION 3 0.0000
355 INJECTION SITE PRURITUS 1 0.0000
356 HEPATIC ENZYME INCREASED 1 0.0000
357 ERYTHEMA 3 0.0000
358 INJECTION SITE REACTION 1 0.0000
359 PYREXIA 5 0.0000
360 WEIGHT DECREASED 4 0.0000
361 INJURY 1 0.0000
362 SLEEP DISORDER 1 0.0000
363 SKIN BURNING SENSATION 1 0.0000
364 RESPIRATORY FAILURE 1 0.0000
365 PRODUCT DOSE OMISSION ISSUE 4 0.0000
366 BRONCHITIS 1 0.0000
367 DYSGEUSIA 1 0.0000
368 ACNE 1 0.0000
369 DEPRESSION 3 0.0000
370 DIABETES MELLITUS 1 0.0000
371 BLOOD PRESSURE INCREASED 2 0.0000
372 INJECTION SITE SWELLING 1 0.0000
373 FATIGUE 10 0.0000
374 ARTHRITIS 1 0.0000
375 PARAESTHESIA 2 0.0000
376 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
377 DYSPNOEA 7 0.0000
378 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
379 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
380 URTICARIA 2 0.0000
381 BALANCE DISORDER 1 0.0000
382 MUSCULOSKELETAL STIFFNESS 1 0.0000
383 PAIN 7 0.0000
384 ADVERSE DRUG REACTION 1 0.0000
385 NASOPHARYNGITIS 2 0.0000
386 ASTHENIA 4 0.0000
387 ANXIETY 3 0.0000
388 ANAEMIA 2 0.0000
389 MIGRAINE 1 0.0000
390 ATRIAL FIBRILLATION 1 0.0000
391 ALOPECIA 2 0.0000
392 PAIN IN EXTREMITY 3 0.0000
393 FLUSHING 1 0.0000
394 CHEST DISCOMFORT 1 0.0000
395 SINUSITIS 1 0.0000
396 ABDOMINAL PAIN UPPER 2 0.0000
397 PLATELET COUNT DECREASED 1 0.0000
398 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
399 RASH 4 0.0000
400 FALL 3 0.0000
401 INFLUENZA 1 0.0000
402 SEPSIS 1 0.0000
403 ASTHMA 1 0.0000
404 MUSCULAR WEAKNESS 1 0.0000
405 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
406 CHILLS 1 0.0000
407 INJECTION SITE ERYTHEMA 1 0.0000
408 HYPERHIDROSIS 1 0.0000
409 DIARRHOEA 5 0.0000
410 RENAL FAILURE 1 0.0000
411 INSOMNIA 2 0.0000
412 NEUTROPENIA 1 0.0000
413 MEMORY IMPAIRMENT 1 0.0000
414 ARTHRALGIA 3 0.0000
415 COUGH 2 0.0000
416 INFECTION 1 0.0000
417 MALAISE 3 0.0000
418 PERIPHERAL SWELLING 1 0.0000
419 NAUSEA 5 0.0000
420 CONFUSIONAL STATE 1 0.0000
421 DRUG DOSE OMISSION 1 0.0000
422 TREMOR 1 0.0000
423 TOXICITY TO VARIOUS AGENTS 1 0.0000
424 MYALGIA 1 0.0000
425 URINARY TRACT INFECTION 1 0.0000
426 MYOCARDIAL INFARCTION 1 0.0000
427 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
428 CHEST PAIN 1 0.0000
429 PRODUCT USE ISSUE 1 0.0000
430 BLOOD GLUCOSE INCREASED 1 0.0000
431 HEADACHE 3 0.0000
432 HYPERTENSION 1 0.0000
433 DRUG INEFFECTIVE 6 0.0000
434 DECREASED APPETITE 1 0.0000
435 DIZZINESS 2 0.0000
436 PNEUMONIA 1 0.0000
437 DEATH 1 0.0000